| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |